Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Nausea 1

Interventions

Dexamethasone 13Ondansetron 9Granisetron 7Palonosetron 5Olanzapine 5Aprepitant 5casopitant 3Radiotherapy 3Prochlorperazine 2Electroacupuncture 2Analgesia 2Acupressure 2sinomenine 1netupitant, palosentron drug combination 1netupitant 1lerisetron 1fosaprepitant 1dolasetron 1dexamethasone acetate 1Therapeutics 1Thalidomide 1Taxes 1Surveys and Questionnaires 1Sugars 1Metoclopramide 1Hygiene 1Haloperidol 1Gemcitabine 1Gabapentin 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Nausea × lerisetron × Clear all
NCT00004219 2013-08-02

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

National Cancer Institute (NCI)

Phase 3 Unknown
150 enrolled
Genitourinary

Testicular Germ Cell Tumor, Nausea, Testicular Neoplasms, Vomiting, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡